SurModics Competitors and Similar CompaniesClear all
SurModics's competitors and similar companies include Nanosonics, SomaLogic and Vascular BioSciences.
 SurModics SurModics is a provider of surface modification, drug delivery and in vitro diagnostic technologies to the healthcare industry. |  SomaLogic SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics. |  Vascular BioSciences Vascular BioSciences (VBS) is a biopharmaceutical and medical device company focused on cardiovascular and inflammatory diseases. | ||
Founding Date | Founding Date 1979 | Founding Date 2001 | Founding Date 2000 | Founding Date 1995 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Eden Prairie, US HQ Galway, IE Eden Prairie, US | Locations Lane Cove West, AU HQ Gif Sur Yvette, FR Hamburg, DE Shibuya, JP Clayton West, GB Indianapolis, US | Locations Boulder, US HQ | Locations Goleta, US HQ Durham, US |
Employees | Employees 3699% increase | Employees 466 | Employees 483 | Employees 267% decrease |
Valuation ($) | Valuation ($) 539.3 m | Valuation ($) 760.8 m | Valuation ($) 396.2 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $126.1m (FY, 2024) | Revenue (est.) $198.6m (FY, 2025) | Revenue (est.) $97.7m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods $33m (FY, 2024) | Cost of goods $35.2m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $93.1m (FY, 2024) | Gross profit $164.7m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($11.5m) (FY, 2024) | Net income $20.7m (FY, 2025) | Net income ($109.2m) (FY, 2022) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Nanosonics
HQ
Lane Cove West, AU
Employees
466
Nanosonics is a company that specializes in the field of infection prevention.
View companySomaLogic
HQ
Boulder, US
Employees
483
SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics.
View companyVascular BioSciences
HQ
Goleta, US
Employees
26↓ 7% decrease
Vascular BioSciences (VBS) is a biopharmaceutical and medical device company focused on cardiovascular and inflammatory diseases.
View company